(Q37235629)

19 August 2017

1 reference

title

Pharmacogenomic importance of ABCG2. (English)

1 reference

19 August 2017

1 reference

2

Alex Sparreboom

1 reference

19 August 2017

George Cusatis

1

1 reference

19 August 2017

1 August 2008

1 reference

19 August 2017

1 reference

19 August 2017

9

1 reference

19 August 2017

1005-1009

1 reference

19 August 2017

8

1 reference

Pharmacogenomics of ABC transporters and its role in cancer chemotherapy.

19 August 2017

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1005

ABCG2 (breast cancer resistance protein/mitoxantrone resistance-associated protein) ATPase assay: a useful tool to detect drug-transporter interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1005

New inhibitors of ABCG2 identified by high-throughput screening

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1005

High-throughput flow cytometry to detect selective inhibitors of ABCB1, ABCC1, and ABCG2 transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1005

A global drug inhibition pattern for the human ATP-binding cassette transporter breast cancer resistance protein (ABCG2).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1005

The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1005

Multidrug transporter ABCG2/breast cancer resistance protein secretes riboflavin (vitamin B2) into milk

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1005

Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1005

Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1005

ABCG2 pharmacogenetics: ethnic differences in allele frequency and assessment of influence on irinotecan disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1005

Ubiquitin-mediated proteasomal degradation of non-synonymous SNP variants of human ABC transporter ABCG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1005

Association of breast cancer resistance protein/ABCG2 phenotypes and novel promoter and intron 1 single nucleotide polymorphisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1005

Disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in relation to ABC transporter genotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1005

Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1005

Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1005

Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1005

Pharmacogenetic characterization of sulfasalazine disposition based on NAT2 and ABCG2 (BCRP) gene polymorphisms in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1005

Inhibition of the epidermal growth factor receptor increases expression of genes that stimulate inflammation, apoptosis, and cell attachment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1005

Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1005

Influence of ABCB1, ABCC1, ABCC2, and ABCG2 haplotypes on the cellular exposure of nelfinavir in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1005

SLCO1B1 (OATP1B1, an uptake transporter) and ABCG2 (BCRP, an efflux transporter) variant alleles and pharmacokinetics of pitavastatin in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1005

The identification of two germ-line mutations in the human breast cancer resistance protein gene that result in the expression of a low/non-functional protein

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1005

Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1005

Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1005

10.2217/14622416.9.8.1005

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

18681776